Onboarding an expert-imaging group in your clinical trials is essential for success!
Medical Metrics, Inc. is proud to have worked with Optinose on their ReOpen clinical trials, which have recently received FDA approval! A heartfelt thank you to all our amazing collaborators, including our dedicated neuroradiologist readers, Key Opinion Leader consultants, and the incredible project personnel on both teams!
Dr. Mark Schweitzer, MD, expounds on design and reporting considerations for imaging assessments in research publications.
A newly signed law permits the FDA to clear a drug for human clinical trials while bypassing animal trials.
A medical device reimbursement strategy expert recently shared some of his top tips for successful clinical trial design.
Drs. T.J. Mosher and G.E. Gold, two of MMI’s thought leaders, recently were published in a review of the best practices for knee OA imaging in clinical trials.
With the proper consideration and a clear understanding of what you value in a CRO, it is possible to develop an outsourcing strategy that can get your product to market more efficiently and with greater evidence to support it.
A recent survey of industry professionals found that the medical device market is growing increasingly competitive, emphasizing the need for high-quality clinical trial data.
To identify the ideal CRO to meet the imaging needs of your trial, it is important to involve them at the very beginning of the process.
This latest trial, which was conducted at Amsterdam’s Academic Medical Centre, involves sending electronic impulses to implanted electrodes to stimulate the vagus nerve.
A recent study took advantage of Medical Metrics state-of-the-art Quantitative Motion Analysis, or QMA®, software to track the motion of cervical disk replacements with extreme precision.
